170624 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Transferases (2.); Glycosyltransferases (2.4) Pentosyltransferases (2.4.2)
METAL NANOPARTICLE, AND PLASMONIC BIOSENSOR COMPRISING THE SAME
#2MTA-COOPERATIVE PRMT5 INHIBITORS FOR USE IN THE TREATMENT OF CANCER
#3BIOMARKERS AND THEIR USE IN DIAGNOSING PARKINSON'S DISEASE, VITREORETINAL DISEASES, AND AGE-RELATED PATHOLOGIES
#4SCREENING METHODS FOR PARP MODULATORS
#5POLY-ADP RIBOSE (PAR) TRACKER OPTIMIZED SPLIT-PROTEIN REASSEMBLY PAR DETECTION REAGENTS
#6Method for detecting binding to an ADP-ribosyl group or a polymer thereof and a kit for performing said method
#7METHODS FOR DIAGNOSIS AND TREATMENT OF COVID-19
#8Method to Evaluate the Capability of Compounds on the Trapping of Proteins
#9COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#10SCREENING METHODS FOR PARP MODULATORS
#11FAMIN Assay Methods
#12Compounds for use in the treatment of cancer
#13METHODS AND COMPOSITIONS FOR TREATING MELANOMA RESISTANT
#14NICOTINAMIDE ADENINE DINUCLEOTIDE ANALOGUES
#15Compounds and methods used in assessing mono-PARP activity
#16Radiolabeled and fluorescent PARP inhibitors for imaging and radiotherapy
#17Screening methods for PARP modulators
#18Compounds for use in the treatment of cancer
#19COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND TREATMENT OF AGE-RELATED MACULAR DEGENERATION
#20Markers for inflammatory bowel disease
#21COMPOSITIONS AND METHODS FOR THE MODULATION OF DNA DAMAGE RESPONSES USING BAL1 AND BBAP
#22Enzymatic modification of nucleic acids
#23Lateral flow device and method of use
#24METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT
#25Neuroprotective Chemicals and Methods for Identifying and Using Same
#26Markers for inflammatory bowel disease
#27Methods for breast cancer treatment
#28COMPOUNDS AND METHODS USED IN ASSESSING MONO-PARP ACTIVITY
#29Neuroprotective chemicals and methods for identifying and using same
#30NAD analogs and methods of using said NAD analogs in determining ribosylation of proteins with PARP mutants
#31COMPOSITIONS AND METHODS FOR TREATING IMMUNE AND VIRAL DISORDERS AND MODULATING PROTEIN-RNA INTERACTION
#32NOVEL METHOD TO DETECT RESISTANCE TO CHEMOTHERAPY IN PATIENTS WITH LUNG CANCER
#33METHODS FOR DIAGNOSIS, PROGNOSIS AND METHODS OF TREATMENT
#34APTAMERS SCREENING METHOD BASED ON GRAPHENE WITHOUT TARGET IMMOBILIZATION AND THE APTAMERS OBTAINED FROM THE METHOD
#35Aptamers screening method based on graphene without target immobilization and the aptamers obtained from the method
#36Compositions and methods for diagnosing, preventing and treating and infection
#37Screening assay for identification of poly(ADP-ribose) polymerase 1 inhibitors
#38Lamin A, an activator of longevity/anti-aging SIRT1 protein
#39NOVEL POLY(ADP-RIBOSE) POLYMERASE GENES
#40ADP-ribose detection reagents
#41Phosphoribosyl pyrophosphate synthetase 2 (PRPS2) as a therapeutic target in cancer treatment
#42Method for monitoring PARP activity in cells by PARP activation
#43Compositions and methods for the modulation of DNA damage responses using BAL1 and BBAP
#44Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance
#45Compositions and methods for treating cancer and modulating stress granule formation
#46Activation and activators of SirT6
#47MARKERS AND ASSAYS FOR DETECTION OF NEUROTOXICITY
#48PARP AND ADJUVANT CISPLATIN-BASED CHEMOTHERAPY IN NON-SMALL-CELL LUNG CANCER
#49METHODS AND KITS FOR MEASURING ENZYME ACTIVITY
#50INTRATUMORAL GENE EXPRESSION LEVELS OF TP AND VEGF ARE ASSOCIATED WITH CLINICAL OUTCOMES IN RECTAL CANCER PATIENTS TREATED WITH 5-FLUOROURACIL AND PELVIC RADIATION
#51REAGENT KIT FOR MEASURING FRESHNESS
#52Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof
#53Method for diagnosing acute cardiac ischemia
#54Methods of identifying anti-cancer agents and uses thereof
#55Poly(ADP-ribose) polymerase genes
#56SIRT4 ACTIVITIES
#57COMPOSITIONS AND METHODS FOR TREATING CANCER AND MODULATING STRESS GRANULE FORMATION
#58Cell culture model for acquired chemoresistance of chronic myelogenous leukemia and related methods for identifying agents to overcome resistance
#59METHOD FOR THE DETECTION OF APOPTOSIS
#60Compositions and methods for identification of PARP function, inhibitors, and activators
#61PARP-BASED CYTOCHEMICAL AND HISTOCHEMICAL DETECTION METHODS AND KITS THEREFORE
#62Process of Screening a Molecule as a Candidate Drug for the Treatment of Bipolar Disorder
#63Method for establishing the sensitivity of tumours to capecitabin and test kit
#64ASSAY METHOD FOR HUMAN OROTATE PHOSPHORIBOSYLTRANSFERASE PROTEIN
#65Methods of identifying anti-cancer agents and uses thereof
#66Assays useful in determining CD38 inhibition
#67Transition state structure and inhibitors of thymidine phosphorylases
#68Sirt4 activities
#69Ups as modifiers of the beta catenin pathway and methods of use
#70SIRT6 transgenic non-human animals and assay methods
#71Method of identifying compounds that induce cell death by necrosis